EFI 2021 A streamlined AlloSeq Tx hybrid capture workflow: DNA to sequencing in a single day.
EFI 2021 Optimization of mixed pools of buccal and peripheral blood DNA for routine testing with AlloSeq Tx…
EFI 2021 Genetic risk factors in solid organ transplantation: beyond classical human leukocyte antigen
EFI 2021 Intra-Laboratory Evaluation of a Next-Generation Sequencing-Based Solution for Chimerism Monitoring
EFI 2021 Laboratory Validation of CE-marked AlloSeq cfDNA to Measure Donor-derived Cell-free DNA in…
EFI 2021 AlloSeq Tx Genotyping Using DNA Extracted from Saliva.
EFI 2021 Accurate, Reproducible and Sensitive Chimerism Monitoring with NGS-based AlloSeq HCT
Decreasing Transplant Wait Times by Increasing Living Donation
HeartCare: The Utility of Multi-Modality in Transplant Patient Care
AlloSure Lung: Donor-Derived Cell Free DNA as an Innovative Biomarker for Lung Transplant Patients
COVID-19 Vaccines and the Latest Data on Immune Response in Transplant Patients
How COVID-19 is Changing Lung Transplant
CareDx 6/6 ATC Symposium: AlloSure- dd-cfDNA Utility Beyond Kidney Transplantation
CareDx 6/7 ATC Symposium: Advancing Care in Kidney Transplantation – Groundbreaking Findings from ADMIRAL…
Ask the Experts: Cancer Risks as a Transplant Recipient
Live Fireside Chat with Erik Compton
Supporting Pediatric Transplant Patients Through Adulthood
2021 ESOT Webinar
ADN libre de células derivado de donante (dd-cfDNA): Vigilancia personalizada no invasiva en postrasplante
AlloSeq cfDNA Webinar 2021, English + Portuguese–Organ Transplant Surveillance with AlloSeq cfDNA
Promoting Living Donation and Increasing Access to Transplantaion
ESOT 2021 – Symposium – Changing the Transplant Care Paradigm Advanced Strategies for Allograft…
Ask the Experts: Delta Variant & COVID-19 Boosters for Transplant Patients
Role of Inflammation and Injury Post Heart Transplantation